Takeda Pharmaceuticals USA Files Data Security Incident Notice in NH
Takeda Pharmaceuticals USA, Inc. has filed a data breach notice with New Hampshire regulators, indicating an ongoing investigation into a security incident. Individuals who receive notification from Takeda should review the information carefully as the company investigates. This filing advises affected parties to remain vigilant.
- State
- NH
- Reported
- May 29, 2026
Takeda Pharmaceuticals USA, Inc. has formally filed a data breach notification with New Hampshire authorities. The filing, dated May 29, 2026, pertains to a recent security incident. Details regarding the exact date of this incident are not available in the public record.
The specific categories of personal information involved in this event are not detailed within the public filing. As such, the nature of the data reportedly exposed or compromised remains broadly described as 'personal information' or 'your data.' No specific types of sensitive data are noted in the available documentation.
At the time of this filing, Takeda Pharmaceuticals USA, Inc. has indicated that the incident is actively under investigation. Further information is expected to emerge as their inquiry progresses and additional findings are confirmed.
Individuals who receive an official notification letter directly from Takeda Pharmaceuticals USA, Inc. are advised to read it thoroughly. This letter will contain the most direct and personalized details about how the incident may affect them.
In general, it is always prudent to monitor your financial accounts and credit reports for any unusual activity. Consider placing a fraud alert or security freeze on your credit files as a preventive measure. Be cautious of unsolicited communications, especially those asking for personal details.
This information is derived from public data breach filings made with state regulatory bodies, serving as a neutral record of reported security incidents.
Source: NH Attorney General filing